Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$19K Sell
497
-625
-56% -$22.8K ﹤0.01% 8082
2014
Q2
$44K Sell
1,122
-8,294
-88% -$319K ﹤0.01% 7033
2014
Q1
$446K Sell
9,416
-7,949
-46% -$352K ﹤0.01% 4357
2013
Q4
$644K Buy
17,365
+16,895
+3,595% +$624K ﹤0.01% 4044
2013
Q3
$17K Hold
470
﹤0.01% 8257
2013
Q2
$15K Buy
+470
New +$13.3K ﹤0.01% 8206

Other funds holding PODD

UBS's PODD Position: Q3 2014 in Review

UBS reduced its Insulet (PODD) stake by 56% in Q3 2014, selling an estimated $22.8K and leaving 497 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #8082.

UBS first reported a position in PODD in Q2 2013 and has held it in 6 quarters since. The position peaked at $644K in Q4 2013. 169 funds tracked by Wall St. Rank hold PODD as of Q3 2014.

  • UBS held 497 shares of Insulet worth $19K as of Q3 2014.
  • UBS sold 625 Insulet shares in Q3 2014, an estimated $22.8K.
  • Insulet made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8082 holding.
  • UBS first reported a position in Insulet in Q2 2013 and has held it in 6 quarters since.
  • UBS's Insulet position peaked at $644K in Q4 2013.
  • 169 funds tracked by Wall St. Rank held Insulet as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.